Evidence map›Paper›PMID 25299782›Full record

ArticleCell death & disease2014

Biological significance of FoxN1 gain-of-function mutations during T and B lymphopoiesis in juvenile mice.

L Ruan, Z Zhang, L Mu, P Burnley, L Wang, B Coder, Q Zhuge, D-M Su

Open access · goldAbstract read
In one paragraph

Article in Cell death & disease, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
0.8field-weighted citation impact, top 32% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 16 citations in OpenAlex.

  1. Review
  2. Article
  3. Foxn1 in Skin Development, Homeostasis and Wound Healing.International journal of molecular sciences · 2018
    Review
  4. Review
  5. Review
  6. Dysfunction of the thymus in mice with hypertension.Experimental and therapeutic medicine · 2017
    Article
  7. Observational
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 4 institutions in 2 countries.

L Ruan1] Zhejiang Provincial Key Laboratory of Aging and Neurological Disorder Research, First Affiliated Hospital, Wenzhou Medical University, Wenzhou, China [2] Department of Cell Biology and Immunology, University of North Texas Health Science Center at Fort Worth, Fort Worth, TX, USA.
Z ZhangDepartment of Cell Biology and Immunology, University of North Texas Health Science Center at Fort Worth, Fort Worth, TX, USA.
L MuDepartment of Cell Biology and Immunology, University of North Texas Health Science Center at Fort Worth, Fort Worth, TX, USA.
P BurnleyDepartment of Cell Biology and Immunology, University of North Texas Health Science Center at Fort Worth, Fort Worth, TX, USA.
L WangDepartment of Cell Biology and Immunology, University of North Texas Health Science Center at Fort Worth, Fort Worth, TX, USA.
B CoderDepartment of Cell Biology and Immunology, University of North Texas Health Science Center at Fort Worth, Fort Worth, TX, USA.
Q ZhugeZhejiang Provincial Key Laboratory of Aging and Neurological Disorder Research, First Affiliated Hospital, Wenzhou Medical University, Wenzhou, China.
D-M Su1] Zhejiang Provincial Key Laboratory of Aging and Neurological Disorder Research, First Affiliated Hospital, Wenzhou Medical University, Wenzhou, China [2] Department of Cell Biology and Immunology, University of North Texas Health Science Center at Fort Worth, Fort Worth, TX, USA.
University of North Texas · USUniversity of North Texas Health Science Center · USFirst Affiliated Hospital of Wenzhou Medical University · CNWenzhou Medical University · CN

Funding

Training in the Neurobiology of Aging and Alzheimer's DiseaseT32AG020494 · NIA · UNIVERSITY OF NORTH TEXAS HLTH SCI CTR · PI ROBERT Clinton BARBER, NATHALIE SUMIEN · 2002 to 2026
$6.9M
Molecular basis for age-related thymic involution and rejuvenationR01AI081995 · NIAID · UNIVERSITY OF TEXAS HLTH CTR AT TYLER · PI SU, DONG-MING · 2009 to 2013
$1.9M
NIAID NIH HHS R01 AI081995NIAID NIH HHS R01AI081995NIA NIH HHS T32 AG020494
6 · The paper itself

Abstract

FoxN1 is cell-autonomously expressed in skin and thymic epithelial cells (TECs), essential for their development. Inborn mutation of FoxN1 results in hair follicle and TEC development failure, whereas insufficient postnatal FoxN1 expression induces thymic atrophy, resulting in declined T lymphopoiesis. Although upregulating FoxN1 expression in the aged FoxN1-declined thymus rejuvenates T lymphopoiesis, whether its over- and ectopic-expression in early life is beneficial for T lymphopoiesis is unknown. Using our newly generated Rosa26-STOP(flox)-FoxN1 mice, in which over- and ectopic-expression of FoxN1 can be induced by various promoter-driven Cre-mediated deletions of the roadblock STOP(flox) in early life, we found that K14Cre-mediated inborn FoxN1 overexpression induced neonatal lethality, exhibited abnormal permeability in the skin and abnormal nursing. Ubiquitous deletion of the STOP(flox) mediated by progressive uCreER(T) leakage in juvenile mice affected thymus and bone marrow normality, resulting in an increased ratio of medullary/cortical TECs, along with declined T and B lymphopoiesis. Although the K5CreER(T)-mediated FoxN1 overexpression mice had a normal lifespan, induction of K5CreER(T) activation in juveniles adversely influenced total thymoycte development and produced ichthyosis-like skin. Therefore, FoxN1 has temporal and tissue-specific activity. Over- and ectopic-expression of FoxN1 in early life adversely influence immature TEC, T and B cell, and skin epithelial development.

Indexed as

LymphopoiesisMutationAnimalsB-LymphocytesBone MarrowEpithelial CellsForkhead Transcription FactorsMiceMice, Inbred C57BLOrgan SpecificitySkinThymus GlandT-LymphocytesForkhead Transcription FactorsWhn protein

Identifiers

PMID25299782
PMCPMC4237256
OpenAlexW1968219944

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.